- Home
- FULC vs CLDT Comparison
FULC vs CLDT Comparison
Compare FULC & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- CLDT
- Stock Information
- Founded
- FULC 2015
- CLDT 2009
- Country
- FULC United States
- CLDT United States
- Employees
- FULC N/A
- CLDT N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- CLDT Real Estate Investment Trusts
- Sector
- FULC Health Care
- CLDT Real Estate
- Exchange
- FULC Nasdaq
- CLDT Nasdaq
- Market Cap
- FULC 375.4M
- CLDT 351.7M
- IPO Year
- FULC 2019
- CLDT 2010
- Fundamental
- Price
- FULC $6.44
- CLDT $6.92
- Analyst Decision
- FULC Buy
- CLDT Strong Buy
- Analyst Count
- FULC 8
- CLDT 2
- Target Price
- FULC $7.13
- CLDT $10.75
- AVG Volume (30 Days)
- FULC 984.6K
- CLDT 213.3K
- Earning Date
- FULC 07-29-2025
- CLDT 08-06-2025
- Dividend Yield
- FULC N/A
- CLDT 5.28%
- EPS Growth
- FULC N/A
- CLDT N/A
- EPS
- FULC N/A
- CLDT 0.03
- Revenue
- FULC N/A
- CLDT $310,140,000.00
- Revenue This Year
- FULC N/A
- CLDT N/A
- Revenue Next Year
- FULC N/A
- CLDT $1.12
- P/E Ratio
- FULC N/A
- CLDT $248.36
- Revenue Growth
- FULC 2752.05
- CLDT N/A
- 52 Week Low
- FULC $2.32
- CLDT $5.83
- 52 Week High
- FULC $10.13
- CLDT $10.00
- Technical
- Relative Strength Index (RSI)
- FULC 39.24
- CLDT 43.83
- Support Level
- FULC $6.47
- CLDT $6.59
- Resistance Level
- FULC $7.00
- CLDT $7.00
- Average True Range (ATR)
- FULC 0.57
- CLDT 0.17
- MACD
- FULC -0.12
- CLDT -0.01
- Stochastic Oscillator
- FULC 5.42
- CLDT 30.86
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.